Oncotarget: A Scion of Open Access Scholarly Information Dissemination

Oncotarget’s reputation within the scholarly circles has risen meteorically since its founding in 2010. The multi-peer reviewed, medical journal operates within the unique niche of open access niche market where many journals have failed to establish their authority. The weekly journal’s success and growing popularity have been built on three fundamental pillars: open access, experienced editorial board and team, and broad range of disciplines it covers. Published by Impact Journals, Oncotarget accepts research articles from researches drawn from all over the world. After multiple peer reviews, the articles are published online with a few hard copies published for special editions and on demand. This is further promoted by the popularity of the journal’s language of choice: English. The journal is peer reviewed and is published by Impact Journals.

Multiple Peer Reviews: Towards High Quality and Credible Articles

Oncotarget has an editorial team comprising of dozens of experienced and highly qualified professionals. The editors are specialists in a wide range of fields ranging from oncology to cell biology and molecular biology. The team is headed by the award-winning research scientists Andrei V. Gudkov and Mikhail Blagosklonny who are the founding editors-in-chief. The high quality and credible articles published in the journal have played a key role in the exponential growth of the journal’s Impact Factor. The number of citations of the journals has increased many folds since its establishment. In 2011, the journal was cited 493 times translating to an Impact Factor of 4.784. However, the latest 2016/2017 IF figures released by Thomson Reuters JCR show that Oncotarget has an IF of 5.168 following 30241 citations. This almost tripled the 2015/2016 citations of 10452. In 2015, the journal was ranked number one on the basis of total number of articles published.

A Multidisciplinary Approach to Scholarly Information Dissemination

Oncotarget was initially established as weekly medical journal dedicated to promoting research and information dissemination on oncology. However, the journal has brought on board numerous editors from various academic backgrounds, which has enabled it expand its disciplines. The incorporation of new disciplines is also in line with the journal’s commitment towards a disease-free world. Therefore, the journal accepts research articles covering other fields such as metabolism, cardiology, cell biology and endocrinology. Consumers of research materials and researchers can also rely on Oncotarget to provide peer-reviews articles on neuroscience and pharmacology among other fields. Visit Oncotarget’s profile page at facebook.com